Cleansing Statement
Released
Released
Announcement PDF
ASX Announcement
11 September 2023
Cleansing Notice Under Section 708A(5)(E) of the Corporations Act
Recce Pharmaceuticals Ltd (ASX:RCE) (Company) has today issued 396,565 fully paid ordinary shares
following the exercise of options as detailed in the Appendix 2A.
The Company gives this notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Corporations
Act) and states the following:
1. the abovementioned ordinary shares were issued without disclosure to investors under Part 6D.2
of the Corporations Act;
2. as at the date of this notice, the Company has complied with:
a) the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and
b) section 674 of the Corporations Act;
3. as at the date of this notice, there is no excluded information for the purposes of sections 708A(7)
and 708A(8) of the Corporations Act.
This announcement has been approved for release by the Board.
For more information, please contact:
James Graham
Chief Executive Officer
+61 2 9256 2571
Share your feedback
Discover